179 related articles for article (PubMed ID: 12231209)
1. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies.
Bardag-Gorce F; van Leeuwen FW; Nguyen V; French BA; Li J; Riley N; McPhaul LW; Lue YH; French SW
Exp Mol Pathol; 2002 Oct; 73(2):75-83. PubMed ID: 12231209
[TBL] [Abstract][Full Text] [Related]
2. The Mallory body as an aggresome: in vitro studies.
Riley NE; Li J; Worrall S; Rothnagel JA; Swagell C; van Leeuwen FW; French SW
Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1).
Bardag-Gorce F; Riley N; Nguyen V; Montgomery RO; French BA; Li J; van Leeuwen FW; Lungo W; McPhaul LW; French SW
Exp Mol Pathol; 2003 Apr; 74(2):160-7. PubMed ID: 12710947
[TBL] [Abstract][Full Text] [Related]
4. Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study.
Bardag-Gorce F; French BA; Lue YH; Nguyen V; Wan YJ; French SW
Exp Mol Pathol; 2001 Feb; 70(1):7-18. PubMed ID: 11170786
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens.
Riley NE; Li J; McPhaul LW; Bardag-Gorce F; Lue YH; French SW
Exp Mol Pathol; 2003 Apr; 74(2):168-72. PubMed ID: 12710948
[TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation.
Bardag-Gorce F; Riley NE; Nan L; Montgomery RO; Li J; French BA; Lue YH; French SW
Exp Mol Pathol; 2004 Feb; 76(1):9-16. PubMed ID: 14738863
[TBL] [Abstract][Full Text] [Related]
7. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.
Nan L; Dedes J; French BA; Bardag-Gorce F; Li J; Wu Y; French SW
Exp Mol Pathol; 2006 Jun; 80(3):228-40. PubMed ID: 16563375
[TBL] [Abstract][Full Text] [Related]
8. SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model.
Bardag-Gorce F; Oliva J; Li J; French BA; French SW
Exp Mol Pathol; 2010 Jun; 88(3):353-62. PubMed ID: 20223233
[TBL] [Abstract][Full Text] [Related]
9. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin.
French BA; van Leeuwen F; Riley NE; Yuan QX; Bardag-Gorce F; Gaal K; Lue YH; Marceau N; French SW
Exp Mol Pathol; 2001 Dec; 71(3):241-6. PubMed ID: 11733949
[TBL] [Abstract][Full Text] [Related]
10. Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study.
Riley NE; Bardag-Gorce F; Montgomery RO; Li J; Lungo W; Lue YH; French SW
Exp Mol Pathol; 2003 Apr; 74(2):173-9. PubMed ID: 12710949
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling.
de Diego JL; Katz JM; Marshall P; Gutiérrez B; Manning JE; Nussenzweig V; González J
Biochemistry; 2001 Jan; 40(4):1053-62. PubMed ID: 11170428
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of the 26S proteasome complex catalyzing ATP-dependent breakdown of ubiquitin-ligated proteins from rat liver.
Ugai S; Tamura T; Tanahashi N; Takai S; Komi N; Chung CH; Tanaka K; Ichihara A
J Biochem; 1993 Jun; 113(6):754-68. PubMed ID: 8396572
[TBL] [Abstract][Full Text] [Related]
13. Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin-ligated proteins by closely linked mechanisms.
Kanayama HO; Tamura T; Ugai S; Kagawa S; Tanahashi N; Yoshimura T; Tanaka K; Ichihara A
Eur J Biochem; 1992 Jun; 206(2):567-78. PubMed ID: 1317798
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1 inhibition enhances mallory body formation.
Bardag-Gorce F; Wilson L; Nan L; Li J; French BA; Morgan TR; Morgan K; French SW
Exp Mol Pathol; 2005 Jun; 78(3):207-11. PubMed ID: 15924872
[TBL] [Abstract][Full Text] [Related]
15. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
16. FAT10 knock out mice livers fail to develop Mallory-Denk bodies in the DDC mouse model.
French SW; French BA; Oliva J; Li J; Bardag-Gorce F; Tillman B; Canaan A
Exp Mol Pathol; 2012 Dec; 93(3):309-14. PubMed ID: 22981937
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition induces cytokeratin accumulation in vivo.
Bardag-Gorce F; Vu J; Nan L; Riley N; Li J; French SW
Exp Mol Pathol; 2004 Apr; 76(2):83-9. PubMed ID: 15010285
[TBL] [Abstract][Full Text] [Related]
18. RNA interference of VCP/p97 increases Mallory body formation.
Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Wilson LT; Khanh Nguyen S; French SW
Exp Mol Pathol; 2005 Feb; 78(1):1-9. PubMed ID: 15596054
[TBL] [Abstract][Full Text] [Related]
19. Mallory body induction in drug-primed mouse liver.
Yuan QX; Marceau N; French BA; Fu P; French SW
Hepatology; 1996 Sep; 24(3):603-12. PubMed ID: 8781332
[TBL] [Abstract][Full Text] [Related]
20. The p105/50 NF-kappaB pathway is essential for Mallory body formation.
Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Wilson LT; French SW
Exp Mol Pathol; 2005 Jun; 78(3):198-206. PubMed ID: 15924871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
